f:I[4569,["674","static/chunks/674-9c99ccbf1bd95097.js","477","static/chunks/477-5122fc8b70b282a4.js","502","static/chunks/502-5ef571bab8f332b8.js","267","static/chunks/app/%5Blang%5D/news/page-7926c9634663144f.js"],"Navigation"] 11:I[6434,["674","static/chunks/674-9c99ccbf1bd95097.js","477","static/chunks/477-5122fc8b70b282a4.js","502","static/chunks/502-5ef571bab8f332b8.js","267","static/chunks/app/%5Blang%5D/news/page-7926c9634663144f.js"],"Image"] 12:I[7184,["674","static/chunks/674-9c99ccbf1bd95097.js","477","static/chunks/477-5122fc8b70b282a4.js","502","static/chunks/502-5ef571bab8f332b8.js","267","static/chunks/app/%5Blang%5D/news/page-7926c9634663144f.js"],"default"] 13:I[4868,["674","static/chunks/674-9c99ccbf1bd95097.js","477","static/chunks/477-5122fc8b70b282a4.js","502","static/chunks/502-5ef571bab8f332b8.js","267","static/chunks/app/%5Blang%5D/news/page-7926c9634663144f.js"],"default"] 14:I[2317,["674","static/chunks/674-9c99ccbf1bd95097.js","477","static/chunks/477-5122fc8b70b282a4.js","502","static/chunks/502-5ef571bab8f332b8.js","267","static/chunks/app/%5Blang%5D/news/page-7926c9634663144f.js"],""] 10:T4e7,

Avinnogen announced that it has succeeded in producing high-quality recombinant proteins using gene-edited chickens with CRISPR-Cas9 gene editing technology for the first time in the world.

This technological development is considered an innovative achievement that overcomes the limitations of existing drug production methods. In particular, eggs can now be used as bioreactors to efficiently produce large quantities of high-quality proteins.

Key technological achievements

Precise gene editing using CRISPR-Cas9 technology
Stable protein production through gene-edited chickens
30% improved production efficiency compared to existing methods
Obtained high-quality recombinant proteins with 99.9% purity

The Avinnogen research team said, "This achievement presents a new paradigm in the field of biopharmaceutical production," and "We plan

NEWS

Latest News